Editorial Comment on “From Test Accuracy to Clinical Risk Interpretation: A Bayesian Perspective on Pre‐Biopsy Biomarkers”

Shingo Hatakeyama

Open source

DOI
10.1111/iju.70648
Published
2026-09
Container
International Journal of Urology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/iju.70648,
  title = {Editorial Comment on “From Test Accuracy to Clinical Risk Interpretation: A Bayesian Perspective on Pre‐Biopsy Biomarkers”},
  author = {Shingo Hatakeyama},
  year = {2026},
  journal = {International Journal of Urology},
  doi = {10.1111/iju.70648},
  url = {https://doi.org/10.1111/iju.70648}
}

RIS

TY  - JOUR
TI  - Editorial Comment on “From Test Accuracy to Clinical Risk Interpretation: A Bayesian Perspective on Pre‐Biopsy Biomarkers”
AU  - Shingo Hatakeyama
PY  - 2026
JO  - International Journal of Urology
DO  - 10.1111/iju.70648
UR  - https://doi.org/10.1111/iju.70648
ER  - 

APA

Hatakeyama, S. (2026). Editorial Comment on “From Test Accuracy to Clinical Risk Interpretation: A Bayesian Perspective on Pre‐Biopsy Biomarkers”. International Journal of Urology. https://doi.org/10.1111/iju.70648

Source records